Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Operations (2023 - 2025)

Historic Cash from Operations for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to -$11.2 million.

  • Camp4 Therapeutics' Cash from Operations fell 1572.27% to -$11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.2 million, marking a year-over-year decrease of 242.09%. This contributed to the annual value of -$45.6 million for FY2024, which is 327.26% down from last year.
  • As of Q3 2025, Camp4 Therapeutics' Cash from Operations stood at -$11.2 million, which was down 1572.27% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Cash from Operations ranged from a high of -$9.7 million in Q3 2024 and a low of -$14.3 million during Q1 2025
  • Its 3-year average for Cash from Operations is -$11.7 million, with a median of -$11.3 million in 2024.
  • Examining YoY changes over the last 5 years, Camp4 Therapeutics' Cash from Operations showed a top increase of 2313.59% in 2025 and a maximum decrease of 2833.17% in 2025.
  • Quarter analysis of 3 years shows Camp4 Therapeutics' Cash from Operations stood at -$11.8 million in 2023, then increased by 3.88% to -$11.3 million in 2024, then increased by 0.96% to -$11.2 million in 2025.
  • Its Cash from Operations stands at -$11.2 million for Q3 2025, versus -$10.3 million for Q2 2025 and -$14.3 million for Q1 2025.